Corrigendum: Use of Anti-angiogenic Drugs Potentially Associated With an Increase on Serum AST, LDH, CK, and CK-MB Activities in Patients With Cancer: A Retrospective Study

Zheng, Qi; Wang, Hanzhou; Hou, Wei; Zhang, Ying

doi:10.3389/fcvm.2021.828274

CORRECTION article

Front. Cardiovasc. Med., 06 January 2022

Sec. Cardio-Oncology

Volume 8 - 2021 | https://doi.org/10.3389/fcvm.2021.828274

Corrigendum: Use of Anti-angiogenic Drugs Potentially Associated With an Increase on Serum AST, LDH, CK, and CK-MB Activities in Patients With Cancer: A Retrospective Study

This article is a correction to:

Use of Anti-angiogenic Drugs Potentially Associated With an Increase on Serum AST, LDH, CK, and CK-MB Activities in Patients With Cancer: A Retrospective Study
1. Read original article

$\nQi Zheng,$ Qi Zheng^1,2

Hanzhou Wang¹

Wei Hou^1,2^*

Ying Zhang^1,2^*

¹Department of Pneumology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China
²Department of Oncology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China

A Corrigendum on
Use of Anti-angiogenic Drugs Potentially Associated With an Increase on Serum AST, LDH, CK, and CK-MB Activities in Patients With Cancer: A Retrospective Study

by Zheng, Q., Wang, H., Hou, W., and Zhang, Y. (2021). Front. Cardiovasc. Med. 8:755191. doi: 10.3389/fcvm.2021.755191

In the published article, there was an error regarding the affiliation for Qi Zheng, Wei Hou and Ying Zhang. As well as having affiliation 1, they should have “Department of Oncology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: anti-angiogenic drugs, cancer, AST, LDH, CK, CK-MB

Citation: Zheng Q, Wang H, Hou W and Zhang Y (2022) Corrigendum: Use of Anti-angiogenic Drugs Potentially Associated With an Increase on Serum AST, LDH, CK, and CK-MB Activities in Patients With Cancer: A Retrospective Study. Front. Cardiovasc. Med. 8:828274. doi: 10.3389/fcvm.2021.828274

Received: 03 December 2021; Accepted: 06 December 2021;
Published: 06 January 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Zheng, Wang, Hou and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Ying Zhang, enlsenk1MDEmI3gwMDA0MDsxNjMuY29t; Wei Hou, aG91d2VpMTk2NCYjeDAwMDQwOzE2My5jb20=

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.